|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sun P, Xiang JB and Chen ZY: Meta-analysis
of adjuvant chemotherapy after radical surgery for advanced gastric
cancer. Br J Surg. 96:26–33. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hershko A and Ciechanover A: The ubiquitin
system. Annu Rev Biochem. 67:425–479. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Varshavsky A: The ubiquitin system, an
immense realm. Annu Rev Biochem. 81:167–176. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Eldridge AG and O'Brien T: Therapeutic
strategies within the ubiquitin proteasome system. Cell Death
Differ. 17:4–13. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Reymond A, Meroni G, Fantozzi A, Merla G,
Cairo S, Luzi L, Riganelli D, Zanaria E, Messali S, Cainarca S, et
al: The tripartite motif family identifies cell compartments. EMBO
J. 20:2140–2151. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kakizuka A, Miller WH Jr, Umesono K,
Warrell RP Jr, Frankel SR, Murty VV, Dmitrovsky E and Evans RM:
Chromosomal translocation t(15;17) in human acute promyelocytic
leukemia fuses RAR alpha with a novel putative transcription
factor, PML. Cell. 66:663–674. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Allton K, Jain AK, Herz HM, Tsai WW, Jung
SY, Qin J, Bergmann A, Johnson RL and Barton MC: Trim24 targets
endogenous p53 for degradation. Proc Natl Acad Sci USA.
106:11612–11616. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sakuma M, Akahira J, Suzuki T, Inoue S,
Ito K, Moriya T, Sasano H, Okamura K and Yaegashi N: Expression of
estrogen-responsive finger protein (Efp) is associated with
advanced disease in human epithelial ovarian cancer. Gynecol Oncol.
99:664–670. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fridell RA, Harding LS, Bogerd HP and
Cullen BR: Identification of a novel human zinc finger protein that
specifically interacts with the activation domain of lentiviral Tat
proteins. Virology. 209:347–357. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Albor A, El-Hizawi S, Horn EJ, Laederich
M, Frosk P, Wrogemann K and Kulesz-Martin M: The interaction of
Piasy with Trim32, an E3-ubiquitin ligase mutated in limb-girdle
muscular dystrophy type 2H, promotes Piasy degradation and
regulates UVB-induced keratinocyte apoptosis through NFkappaB. J
Biol Chem. 281:25850–25866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Watanabe T, Imoto I, Kosugi Y, Ishiwata I,
Inoue S, Takayama M, Sato A and Inazawa J: A novel amplification at
17q21-23 in ovarian cancer cell lines detected by comparative
genomic hybridization. Gynecol Oncol. 81:172–177. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Horn EJ, Albor A, Liu Y, El-Hizawi S,
Vanderbeek GE, Babcock M, Bowden GT, Hennings H, Lozano G, Weinberg
WC and Kulesz-Martin M: RING protein Trim32 associated with skin
carcinogenesis has anti-apoptotic and E3-ubiquitin ligase
properties. Carcinogenesis. 25:157–167. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kano S, Miyajima N, Fukuda S and
Hatakeyama S: Tripartite motif protein 32 facilitates cell growth
and migration via degradation of Abl-interactor 2. Cancer Res.
68:5572–5580. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu J, Zhang C, Wang XL, Ly P, Belyi V,
Xu-Monette ZY, Young KH, Hu W and Feng Z: E3 ubiquitin ligase
TRIM32 negatively regulates tumor suppressor p53 to promote
tumorigenesis. Cell Death Differ. 21:1792–1804. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sobin L, Gospodarowicz M and Wittekind C:
TNM classification of malignant tumours. 7th. New Jersey;
Wiley-Blackwell; 2009
|
|
17
|
Robertson JF, Nicholson RI, Bundred NJ,
Anderson E, Rayter Z, Dowsett M, Fox JN, Gee JM, Webster A,
Wakeling AE, et al: Comparison of the short-term biological effects
of 7alpha-
[9-(4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl]estra-1,3,5,
(10)-triene-3,17beta-diol (Faslodex) versus tamoxifen in
postmenopausal women with primary breast cancer. Cancer Res.
61:6739–6746. 2001.PubMed/NCBI
|
|
18
|
Ye Y, Li X, Yang J, Miao S, Wang S, Chen
Y, Xia X, Wu X, Zhang J, Zhou Y, et al: MDM2 is a useful prognostic
biomarker for resectable gastric cancer. Cancer Sci. 104:590–598.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Masuda TA, Inoue H, Sonoda H, Mine S,
Yoshikawa Y, Nakayama K, Nakayama K and Mori M: Clinical and
biological significance of S-phase kinase-associated protein 2
(Skp2) gene expression in gastric carcinoma: Modulation of
malignant phenotype by Skp2 overexpression, possibly via p27
proteolysis. Cancer Res. 62:3819–3825. 2002.PubMed/NCBI
|
|
20
|
Bai J, Zhou Y, Chen G, Zeng J, Ding J, Tan
Y, Zhou J and Li G: Overexpression of Cullin1 is associated with
poor prognosis of patients with gastric cancer. Hum Pathol.
42:375–383. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Migita K, Takayama T, Matsumoto S,
Wakatsuki K, Tanaka T, Ito M, Nishiwada S and Nakajima Y:
Prognostic impact of RING box protein-1 (RBX1) expression in
gastric cancer. Gastric Cancer. 17:601–609. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sawada G, Ueo H, Matsumura T, Uchi R,
Ishibashi M, Mima K, Kurashige J, Takahashi Y, Akiyoshi S, Sudo T,
et al: Loss of COP1 expression determines poor prognosisin patients
with gastric cancer. Oncol Rep. 30:1971–1975. 2013.PubMed/NCBI
|
|
23
|
Gan L, Liu DB, Lu HF, Long GX, Mei Q, Hu
GY, Qiu H and Hu GQ: Decreased expression of the carboxyl terminus
of heat shock cognate 70 interacting protein in human gastric
cancer and its clinical significance. Oncol Rep. 28:1392–1398.
2012.PubMed/NCBI
|
|
24
|
Yokoe T, Toiyama Y, Okugawa Y, Tanaka K,
Ohi M, Inoue Y, Mohri Y, Miki C and Kusunoki M: KAP1 is associated
with peritoneal carcinomatosis in gastric cancer. Ann Surg Oncol.
17:821–828. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kosaka Y, Inoue H, Ohmachi T, Yokoe T,
Matsumoto T, Mimori K, Tanaka F, Watanabe M and Mori M: Tripartite
motif-containing 29 (TRIM29) is a novel marker for lymph node
metastasis in gastric cancer. Ann Surg Oncol. 14:2543–2549. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang Z, Zhang N, Zha L, Mao HC, Chen X,
Xiang JF, Zhang H and Wang ZW: Aberrant expression of the autocrine
motility factor receptor correlates with poor prognosis and
promotes metastasis in gastric carcinoma. Asian Pac J Cancer Prev.
15:989–997. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schlabach MR, Luo J, Solimini NL, Hu G, Xu
Q, Li MZ, Zhao Z, Smogorzewska A, Sowa ME, Ang XL, et al: Cancer
proliferation gene discovery through functional genomics. Science.
319:620–624. 2008. View Article : Google Scholar : PubMed/NCBI
|
